US EditionNew RNA-based liquid biopsy detects early colorectal cancer with high accuracy
4 Articles
4 Articles
The liquid biopsies allow you to detect cancer signs through a blood analysis, but they are not as accurate in the initial stages of the disease as traditional biopsies, studies show.
U.S. scientists have developed a new liquid biopsy test that uses RNA modifications to detect colorectal cancer in its early stage. The test was able to detect the early stages of the disease with an accuracy of 95%, a considerable improvement in respect to current available methods. Liquid biopsies are tests that detect signs of cancer by simple blood extraction and that, unlike traditional biopsies, which need a tissue sample, usually look for…
New RNA-based liquid biopsy detects early colorectal cancer with high accuracy
Liquid biopsies are tests that detect signs of cancer through a simple blood draw. Unlike traditional biopsies, which require removing a piece of tissue, a liquid biopsy typically looks for mutations or modification changes in fragments of DNA from cancer cells circulating in the blood.
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
